Zlab Receives PMTA Filing Letter for 78 Products
Shenzhen Yibo Technology Co. has received a filing letter from the U.S. Food and Drug Administration (FDA) for its premarket tobacco product application (PMTA). The company submitted the PMTA before the Sept. 9 deadline.
The company is now allowed to market its ZLab brand of pods, disposable e-cigarettes and e-juice for up to 1 year or until the FDA takes action on its PMTA submission. On the market since 2015, Zlab’s PMTA includes 13 flavors in six different nicotine strengths totalizing 78 different SKUs, according to a press release.
ZLab has over 20,000 points of sale in the US market. They currently have offices in 12 countries with revenues close to $300 million a year, according to the release. ZLab states that it is planning to submit 120 more PMTA applications in 2021, including an application for a new pod system, which should be launched at the beginning of 2022.